Paris, France, – Cellectis (Alternext: ALCLS), the genome engineering specialist, announces today the signing of a broad collaboration agreement with the University College of London (UCL) on the development of a therapy program to fight leukemia. This agreement builds on Cellectis’ therapeutic strategy to treat patients with B-cell leukemias. This therapy uses Cellectis’ proprietary genome […]
At this year’s annual meeting of the American Society for Cell Biology in San Francisco, USA, the Microscopy business group of Carl Zeiss is presenting a Digital Slide Scanner. Axio Scan.Z1 is an automated microscope system which allows researchers to digitalize fixed tissue sections and cytologic specimens in brightfield and fluorescence. Thanks to the tray […]
HERCULES, CA — Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it has signed a definitive agreement to acquire AbD Serotec, a division of MorphoSys AG for 53 million euros in cash. The transaction is subject to certain closing […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has successfully completed beta trials for two new illumigene molecular amplification tests. These assays are designed to specifically detect the DNA of Chlamydia trachomatis and Neisseria gonorrhoeae, respectively, from both swab and urine samples. For the first time, these two new assays will also incorporate […]
Roche today announced plans to invest over 240 million Swiss francs (more than 200 million euros) in its Penzberg biotechnology centre, near Munich, Germany. The plans call for construction of a new production facility, to be known as Diagnostics Operations Complex II (DOCII). The facility is scheduled to be operational in December 2014 and will […]
SAN DIEGO, — Sequenom, Inc. (Nasdaq: SQNM) announced today the appointments of William Welch as the Company’s President and Chief Operating Officer and Dirk van den Boom as the Company’s Executive Vice President, Research & Development and Chief Technology Officer, both effective immediately. Additionally, Ronald Lindsay has been named as the Company’s Executive Vice President, […]
SCIENION’s sciFLEXARRAYER used for the production of Anagnostics’ integrated sepsis testing products
Dortmund, Germany, and St. Valentin, Austria, : SCIENION AG and Anagnostics Bioanalysis GmbH today announced that Anagnostics is using Scienion’s sciFLEXARRAYER for the production of Anagnostics new product line focusing on integrated sepsis testing, based on DNA and protein based multiplex assays. Anagnostics is specialized in developing systems and tests for multiplex diagnostics and has […]
SAN DIEGO, CA –— Genalyte, Inc. today announced that it has been awarded a Small Business Innovation Research (SBIR) grant to develop multiplexed diagnostic assays for the early detection and monitoring of Type 1 diabetes that will run on Genalyte’s innovative MaverickTM Detection System. The $500,000 grant is from the National Institute of Diabetes and […]
BREMEN, Germany—- Bruker today announces multiple placements of MALDI Biotyper systems for rapid, differentiated and cost-effective microbial identification with various local, state and federal authorities and institutes in Germany. These local authorities are responsible for public health, animal health, food safety, consumer protection, agriculture and fisheries. In recent years, European clinical laboratories have been increasingly […]
Appointment of permanent CEO The Board of Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) wishes to announce that, further to the Company’s announcement dated November 28th, 2012, Ms. Alison Mew has been appointed as the permanent Chief Executive Officer of Genetic Technologies Limited. GTG Chairman, Dr. Mal Brandon said “The Board is extremely pleased that […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
